RAC 0.62% $1.64 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-32

  1. 8,512 Posts.
    lightbulb Created with Sketch. 1397
    Interesting.

    My own interpretation is that, provided that the application for paediatric AML doesn't mention any adult indications other than AML, the PRV eligibility for non-AML indications is unaffected.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.64
Change
0.010(0.62%)
Mkt cap ! $278.6M
Open High Low Value Volume
$1.64 $1.64 $1.62 $20.73K 12.78K

Buyers (Bids)

No. Vol. Price($)
2 1440 $1.62
 

Sellers (Offers)

Price($) Vol. No.
$1.64 84 1
View Market Depth
Last trade - 11.13am 11/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.